SAB Zenzele Kabili Holdings (SZK) Fair Value & Analysis
Financial Services · ZA · Market cap 1.4B ZAC
Fair value as of: Jul 19, 2026
From 9 valuation models · updated 22 days ago
Below-average quality, screening 100% undervalued on our models.
What matters now
- The price is below even our cautious bear case (R41.76). The market is more pessimistic than our downside scenario.
- Solid quality (45/100) at a price below fair value, the discount is the argument here, not the business quality.
- A fairly wide model range (R41.76 to R107.27) leaves room in how you read the outcome.
- For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 19, 2026.
How to read this chart
60‑month range R0.3500 – R177.24 · fair‑value band R41.76 – R107.27 · the R33.99 price screens below the R67.98 fair value. Dashed = 300-day average. As of Jul 19, 2026.
Analysis
SAB Zenzele Kabili Holdings (SZK) currently trades at R33.99, while our model-based Fair Value estimate is R67.98, implying the stock looks roughly 100.0% undervalued today. The Quality Score stands at 45/100 (below-average quality), in the Financial Services sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.
Trailing-twelve-month revenue stands at 123M ZAR. Revenue grew 44.4% year over year. It earns a return on equity of 30.1%. Net debt stands at 2.4M ZAR. Fundamentals as of Jul 19, 2026
Our scenario range runs from R41.76 (bear case) to R107.27 (bull case); at R33.99, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. For context, the median of 10 Financial Services peers we cover trades at -61% fair-value upside, at 100%, SZK screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 9 models by family
Widest divergence: Multiples (R92.04) versus Growth DCF (R16.86). Highest evidence: Growth DCF (80).
Notify me when SZK reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 19, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 50 · Market factors (momentum, volatility) 44
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
SAB Zenzele Kabili Holdings (RF) Limited produces, markets, distributes, and sells beer. Its beer brands include Corona and Stella Artois. The company was incorporated in 2019 and is based in Johannesburg, South Africa.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2020 – FY2023 · reported fiscal years
SAB Zenzele Kabili Holdings reported revenue of R0 in FY2023 versus R0 in FY2020. Reported net income was R426M in FY2023.
Watch SZK: get an alert when its fair value changes →
Peer Group
Shell Companies · 70 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Shell Companies median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Shell Companies stocks, each showing price versus our Fair Value estimate (as of Jul 19, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| The Coca-Cola Company COLA | C$27.96 | C$10.91 | -61% |
| Lionheart III Corp LION | $13.47 | $18.15 | +35% |
| Agriculture & Natural Solutions Acquisition Corporation ANSC | $11.45 | $4.13 | -64% |
| AA Mission Acquisition Corp AAM | $0.0320 | $0.0314 | -2% |
| GP-Act III Acquisition Corp GPAT | $10.91 | $4.30 | -61% |
| Berto Acquisition Corp TACO | $10.48 | $2.73 | -74% |
| Axiom Intelligence Acquisition Corp AXIN | $10.29 | $1.46 | -86% |
| Bold Eagle Acquisition Corp BEAG | $10.67 | $4.00 | -63% |
| Lionheart Holdings CUB | $10.80 | $5.06 | -53% |
| Graf Global Corp GRAF | $10.82 | $3.63 | -66% |
Compare SAB Zenzele Kabili Holdings with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Financial Services stocks →
Frequently asked questions
Is SAB Zenzele Kabili Holdings (SZK) overvalued or undervalued?
What is the fair value of SZK?
What is the quality score of SZK?
What is the revenue of SAB Zenzele Kabili Holdings (SZK)?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track SAB Zenzele Kabili Holdings and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.